If your legs move constantly, paired with other sensations such as aching and tingling, you may be experiencing restless legs ...

and pramipexole (Mirapex), which the Food and Drug Administration approved for the treatment of RLS—are sometimes unsuccessful because their effects can wear off over time or even worsen symptoms.

Dopamine agonists are the first-line treatment for RLS; their efficacy has mainly been demonstrated by short-term trials of oral medications. Oertel and colleagues (2011) aimed to determine the ...

More information: John W. Winkelman et al, Treatment of restless legs syndrome and periodic limb movement disorder: an ...

Thousands of Australians are living with restless leg syndrome, but there are treatments available to help manage symptoms.

In those cases, we may do iron infusions.” Certain medications can trigger or exacerbate restless legs syndrome, including antidepressants, thyroid medications, antipsychotics and pain ...

Iron supplements are a common treatment for restless leg syndrome, and they come in various forms, including tablets, capsules, and liquids. However, not all iron supplements are created equal ...

This article examines RLS in the arms, including the causes, treatments, and how to manage it. RLS is a neurological condition, also known as Willis-Ekbom disease. While it primarily affects the ...

With the emergence of new approved treatments and increased public awareness, restless legs syndrome (RLS) is recognized to be the most common sleep related movement disorder. RLS affects up to 7% of ...

The FDA approved Horizant in April 2011. Unlike previous dopamine agonist RLS medications, Horizant's active ingredient is gabapentin. This anticonvulsant drug is approved to treat epilepsy and is ...

However, more research is necessary to understand this. Mild RLS does not always require treatment. But depending on the cause of RLS, there may be ways to reduce it or to manage the symptoms so ...

We conducted a prospective, randomized, double-blinded, sham-controlled trial assessing the therapeutic effect of PCDs for RLS. Patients were randomized in a 3:2 distribution according to a ...